The experiments proposed in this application are designed to elucidate the mechanism(s) by which TGF beta 1 binding transduces a growth stimulatory or growth inhibitory signal. While many investigators utilize TGF beta 1 or TGF beta 1-like molecules, little is known about the mechanism through which the TGF beta 1 signal is transduced to the cell nucleus. Our recent data, however, indicate that a guanine nucleotide regulatory protein (G protein) is coupled to TGF beta 1 binding in mesenchymal and epithelial cells. A model is proposed suggesting that TGF beta 1 affects cellular regulation by at least two distinct mechanisms, one is G protein-independent and the other is G protein-dependent. The G protein-independent pathway is coupled to TGF beta 1-stimulated extracellular matrix/cytoskeletal gene expression while the G protein-dependent pathway regulates soft agar growth and expression of the proto-oncogenes c-sis, c-fos, and c-myc. We wish to expand upon these results and determine the nature of the G protein coupled to the TGF beta 1 receptor(s). This will be accomplished by the following specific aims: 1). determine whether a G protein is coupled to TGF beta 1 binding in transformed cell lines or epithelial cells growth inhibited by TGF beta 1; 2). isolate nontransformed epithelial cell variants refractile to TGF beta 1 growth inhibition with altered or abrogated TGF beta 1/G protein coupling; and 3). purification of the specific G protein coupled to TGF beta 1 binding. A mixture of biochemical, genetic, and molecular approaches are utilized in these studies. Information concerning the mechanism of TGF beta 1 action in normal cellular proliferation and transformation should result.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Fautsch, M P; Eblen, S T; Anders, R A et al. (1995) Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells. J Cell Biochem 58:517-26
Matolcsy, A; Inghirami, G; Knowles, D M (1994) Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 83:1363-72
Eblen, S T; Fautsch, M P; Burnette, R J et al. (1994) Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor beta 1 in cycling epithelial cells. Cell Growth Differ 5:109-16
Inghirami, G; Macri, L; Cesarman, E et al. (1994) Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood 83:3581-90
Chadburn, A; Knowles, D M (1994) Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol 102:284-91
Inghirami, G; Lederman, S; Yellin, M J et al. (1994) Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma. Blood 84:866-72
Inghirami, G; Macri, L; Rosati, S et al. (1994) The Reed-Sternberg cells of Hodgkin disease are clonal. Proc Natl Acad Sci U S A 91:9842-6
Inghirami, G; Szabolcs, M J; Yee, H T et al. (1993) Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Lab Invest 68:746-57
Chadburn, A; Cesarman, E; Jagirdar, J et al. (1993) CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72:3078-90
Haber, M M; Liu, J; Knowles, D M et al. (1992) Determination of the DNA content of the Reed-Sternberg cell of Hodgkin's disease by image analysis. Blood 80:2851-7

Showing the most recent 10 out of 21 publications